Ancora Advisors LLC Decreases Stake in STERIS plc (NYSE:STE)

Ancora Advisors LLC decreased its holdings in STERIS plc (NYSE:STE) by 6.7% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,680 shares of the medical equipment provider’s stock after selling 120 shares during the quarter. Ancora Advisors LLC’s holdings in STERIS were worth $345,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Magnolia Capital Advisors LLC lifted its stake in shares of STERIS by 1.9% in the fourth quarter. Magnolia Capital Advisors LLC now owns 2,534 shares of the medical equipment provider’s stock valued at $521,000 after purchasing an additional 48 shares during the period. Park Edge Advisors LLC increased its holdings in STERIS by 1.1% in the fourth quarter. Park Edge Advisors LLC now owns 4,662 shares of the medical equipment provider’s stock valued at $958,000 after buying an additional 51 shares in the last quarter. Citizens Financial Group Inc. RI lifted its position in shares of STERIS by 5.9% during the 4th quarter. Citizens Financial Group Inc. RI now owns 975 shares of the medical equipment provider’s stock valued at $201,000 after acquiring an additional 54 shares during the period. Opal Wealth Advisors LLC boosted its stake in shares of STERIS by 5.7% during the 4th quarter. Opal Wealth Advisors LLC now owns 1,118 shares of the medical equipment provider’s stock worth $230,000 after acquiring an additional 60 shares in the last quarter. Finally, Sage Private Wealth Group LLC grew its holdings in shares of STERIS by 4.1% in the 4th quarter. Sage Private Wealth Group LLC now owns 1,537 shares of the medical equipment provider’s stock worth $316,000 after acquiring an additional 61 shares during the period. Institutional investors and hedge funds own 94.69% of the company’s stock.

Analyst Upgrades and Downgrades

STE has been the topic of a number of research analyst reports. Needham & Company LLC reiterated a “hold” rating on shares of STERIS in a research report on Monday, April 7th. Stephens reiterated an “overweight” rating and issued a $240.00 price objective on shares of STERIS in a research report on Thursday, February 6th. JMP Securities restated a “market outperform” rating and set a $265.00 target price on shares of STERIS in a report on Thursday, April 10th. Finally, Piper Sandler upped their price target on shares of STERIS from $260.00 to $265.00 and gave the company an “overweight” rating in a report on Monday, February 3rd. One analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat.com, STERIS has a consensus rating of “Moderate Buy” and an average target price of $258.75.

STERIS Trading Down 0.9 %

STERIS stock opened at $222.23 on Wednesday. The stock has a 50-day moving average price of $223.19 and a 200 day moving average price of $218.78. STERIS plc has a 52 week low of $200.98 and a 52 week high of $248.24. The stock has a market cap of $21.83 billion, a PE ratio of 47.18 and a beta of 0.96. The company has a current ratio of 2.13, a quick ratio of 1.40 and a debt-to-equity ratio of 0.32.

STERIS (NYSE:STE) last posted its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing analysts’ consensus estimates of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. Equities research analysts predict that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.